Linked Life Data

6605499

Source:http://linkedlifedata.com/resource/pubmed/id/6605499

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1983-12-17
pubmed:abstractText
The effect of midazolam, a new water-soluble benzodiazepine, on an in vitro slice preparation of the frog spinal cord was investigated using electrophysiological recordings. Midazolam potently (ED50 = 1 nM) enhanced the depolarizing action of GABA on primary afferent fibres while leaving the depolarizing effect of glutamate, glycine or high K+ solutions unchanged. Concentrations of midazolam higher than 100 nM had an antagonistic effect on GABA responses. Ro 14-7437 was a powerful and selective antagonist of the midazolam potentiation without affecting control responses to GABA, glutamate or high K+. The antagonism of GABA responses induced by high doses of midazolam was not sensitive to Ro 14-7437. Our data suggest that midazolam is a very potent and selective modulator of GABA responses: this finding illustrates that electrophysiological techniques can detect specific effects of very low concentrations of benzodiazepines on a CNS slice preparation with well preserved architectural organization.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0304-3940
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-204
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Potentiating action of midazolam on GABA-mediated responses and its antagonism by Ro 14-7437 in the frog spinal cord.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't